We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
For Bilateral MBC, IDC ,G3, TN(ES,Pr,Her2-neqative ) BRCA 1 mut(+) -metastatik (oss/lym) breast cancer all therapy palliative. 1st line palliative therapy-chemotherapy with TP (6 cycls) +zoledronic acid 4mq ( 1year 12 cycls ), concurent or then radiotherapy left femoral head lesion
weekly taxol or cisplatin single agent
? Olaparib ( OlimpiaD)
Olaparib + Zolendronic Acid.
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.